diflucan 200 mg cápsula
laboratórios pfizer, lda. - fluconazol - cápsula - 200 mg - fluconazol 200 mg - fluconazole - n/a - duração do tratamento: longa duração
diflucan 200 mg cápsula
laboratórios pfizer, lda. - fluconazol - cápsula - 200 mg - fluconazol 200 mg - fluconazole - n/a - duração do tratamento: longa duração
diflucan 100 mg cápsula
laboratórios pfizer, lda. - fluconazol - cápsula - 100 mg - fluconazol 100 mg - fluconazole - n/a - duração do tratamento: longa duração
diflucan 50 mg cápsula
laboratórios pfizer, lda. - fluconazol - cápsula - 50 mg - fluconazol 50 mg - fluconazole - n/a - duração do tratamento: longa duração
diflucan 100 mg cápsula
laboratórios pfizer, lda. - fluconazol - cápsula - 100 mg - fluconazol 100 mg - fluconazole - n/a - duração do tratamento: longa duração
diflucan 150 150 mg cápsula
laboratórios pfizer, lda. - fluconazol - cápsula - 150 mg - fluconazol 150 mg - fluconazole - n/a - duração do tratamento: longa duração
pemetrexed pfizer (previously pemetrexed hospira)
pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - agentes antineoplásicos - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.
lorenin 2.5 mg comprimido
laboratórios pfizer, lda. - lorazepam - comprimido - 2.5 mg - lorazepam 2.5 mg - lorazepam - n/a - duração do tratamento: curta ou média duração
lorenin 1 mg comprimido
laboratórios pfizer, lda. - lorazepam - comprimido - 1 mg - lorazepam 1 mg - lorazepam - n/a - duração do tratamento: curta ou média duração
lorenin 1 mg comprimido
laboratórios pfizer, lda. - lorazepam - comprimido - 1 mg - lorazepam 1 mg - lorazepam - n/a - duração do tratamento: curta ou média duração